Neuland Laboratories Reports Q2 Results and Approves ₹47.1 Crore Land Acquisition
Neuland Laboratories Ltd · Others (Uncategorized) · 03 Nov 2026, 9:31 pm
Neuland Laboratories Reports Q2 Results and Approves ₹47.1 Crore Land Acquisition Neuland Laboratories approved Q2 results for the period ended 30th Sep'26, reporting consolidated revenue from operations of ₹44,965.69 lakhs compared to ₹51,427.31 lakhs in Q2 FY25 (YoY) and ₹64,157.71 lakhs in Q1 FY27 (QoQ). Consolidated net profit stood at ₹5,162.50 lakhs versus ₹9,685.39 lakhs in the year-ago quarter, with EPS at ₹40.24. Additionally, the Board approved a capital expenditure of ₹47.1 crores (inclusive of GST) funded entirely via internal accruals to acquire a 6-acre land parcel in Telangana for future capacity expansion.
Original exchange filing (PDF)
More announcements from Neuland Laboratories Ltd
- Intimation about Schedule of Analyst / Institutional Investor Meeting on November 17, 2026 · 06 Nov 2026
- Change in Corporate Office Address of Registrar and Share Transfer Agent (RTA) · 05 Nov 2026
- Audio Recording of the Earnings call conducted on November 3, 2026 · 04 Nov 2026
- Investor Presentation on the Financial Results of the Company for the quarter and half year ended September 30, 2026 · 03 Nov 2026
- Press Release on the Financial Results of the Company for the quarter and half year ended September 30, 2026 · 03 Nov 2026
- Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026 · 03 Nov 2026
- Neuland Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 03 Nov 2026
- Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026 · 03 Nov 2026
